FinscoFinsco

Quest Diagnostics (US.DGX)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.DGX · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion71.2%→
ROE7.6%↑
Cash Conversion153.5%↓
D/E Ratio0.85→
Gross Margin33.2%→
US.DGX (Quest Diagnostics) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion    71.2%    →
ROE                7.6%    ↑
Cash Conversion  153.5%    ↓
D/E Ratio          0.85    →
Gross Margin      33.2%    →
Key Metrics
US.DGX (Quest Diagnostics) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 71.2% →
ROE 7.6% ↑
Cash Conversion 153.5% ↓
D/E Ratio 0.85 →
Gross Margin 33.2% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies